Skip to main content

Table 1 Patient demographics

From: A multicenter evaluation of antibacterial use in hospitalized patients through the SARS-Cov-2 pandemic waves

 

Pre-pandemic

SARS-CoV-2 + 

SARS-CoV-2 -

SARS-CoV-2 not tested

Total admissions (N)

1,789,449

189,115

1,898,659

1,641,521

Male, n (%)

771,770 (43.1%)

95,001 (50.2%)*

832,409 (43.8%)*

705,186 (43.0%)*

Age (years), mean ± SD (median)

58.4 ± 19.7 (61)

61.5 ± 17.9 (63)*

58.5 ± 19.7 (62)*

57.5 ± 19.7 (60)*

Culture collected, n (%)

802,888 (44.9%)

183,658 (97.1%)*

1,685,161

(88. 8%)*

656,516 (40.0%)*

Hospital LOS (days), mean ± SD (median)

4.3 ± 5.8 (3)

7.9 ± 10.5 (5)*

4.8 ± 7.0 (3)*

3.9 ± 6.3 (2)*

ICU admissions, n (%)

213,616 (11.9%)

39,392 (20.8%)*

240,504 (12.7%)*

153,556 (9.4%)*

ICU LOS (days), mean ± SD (median)

3.5 ± 4.7 (2)

8.2 ± 9.7 (5)*

4.0 ± 5.6 (2)*

3.4 ± 4.8 (2)*

  1. ICU intensive care unit, LOS length of stay, SD standard deviation
  2. *P < 0.0008 compared with pre-pandemic period